Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

803 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
Derache A, Iwuji CC, Danaviah S, Giandhari J, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Pillay D, Gupta RK. Derache A, et al. Among authors: dabis f. J Antimicrob Chemother. 2019 Feb 1;74(2):473-479. doi: 10.1093/jac/dky428. J Antimicrob Chemother. 2019. PMID: 30380053 Free PMC article. Clinical Trial.
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.
Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K; CASCADE Virology Collaboration. Pillay D, et al. Among authors: dabis f. AIDS. 2006 Jan 2;20(1):21-8. doi: 10.1097/01.aids.0000196172.35056.b7. AIDS. 2006. PMID: 16327315
Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.
Chaix ML, Ekouevi DK, Peytavin G, Rouet F, Tonwe-Gold B, Viho I, Bequet L, Amani-Bosse C, Menan H, Leroy V, Rouzioux C, Dabis F. Chaix ML, et al. Among authors: dabis f. Antimicrob Agents Chemother. 2007 Mar;51(3):896-901. doi: 10.1128/AAC.00910-06. Epub 2006 Dec 18. Antimicrob Agents Chemother. 2007. PMID: 17178792 Free PMC article. Clinical Trial.
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients.
Pellegrin I, Breilh D, Coureau G, Boucher S, Neau D, Merel P, Lacoste D, Fleury H, Saux MC, Pellegrin JL, Lazaro E, Dabis F, Thiébaut R; ANRS Co3 Aquitaine Cohort. Pellegrin I, et al. Among authors: dabis f. Antimicrob Agents Chemother. 2007 Apr;51(4):1473-80. doi: 10.1128/AAC.00481-06. Epub 2007 Feb 12. Antimicrob Agents Chemother. 2007. PMID: 17296739 Free PMC article.
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.
Wittkop L, Breilh D, Da Silva D, Duffau P, Mercié P, Raymond I, Anies G, Fleury H, Saux MC, Dabis F, Fagard C, Thiébaut R, Masquelier B, Pellegrin I; ANRS CO3 Aquitaine Cohort. Wittkop L, et al. Among authors: dabis f. J Antimicrob Chemother. 2009 Jun;63(6):1251-5. doi: 10.1093/jac/dkp114. Epub 2009 Mar 31. J Antimicrob Chemother. 2009. PMID: 19336453 Free PMC article. Clinical Trial.
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
Benaboud S, Ekouévi DK, Urien S, Rey E, Arrivé E, Blanche S, Gray G, Sim KL, Avit D, McIntyre J, Nerrienet E, Dabis F, Tréluyer JM, Hirt D; TEmAA ANRS 12109 Study Group. Benaboud S, et al. Among authors: dabis f. Antimicrob Agents Chemother. 2011 Jan;55(1):331-7. doi: 10.1128/AAC.00631-10. Epub 2010 Oct 18. Antimicrob Agents Chemother. 2011. PMID: 20956588 Free PMC article. Clinical Trial.
Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2.
Benaboud S, Pruvost A, Coffie PA, Ekouévi DK, Urien S, Arrivé E, Blanche S, Théodoro F, Avit D, Dabis F, Tréluyer JM, Hirt D. Benaboud S, et al. Among authors: dabis f. Antimicrob Agents Chemother. 2011 Mar;55(3):1315-7. doi: 10.1128/AAC.00514-10. Epub 2010 Dec 20. Antimicrob Agents Chemother. 2011. PMID: 21173182 Free PMC article.
803 results